Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome.
ORF73, which encodes the latency-associated nuclear antigen (LANA), is a conserved gamma-2-herpesvirus gene. The murine gammaherpesvirus 68 (MHV68) LANA (mLANA) is critical for efficient virus replication and the establishment of latent infection following intranasal inoculation. To test whether the initial host immune response limits the capacity of mLANA-null virus to traffic to and establish latency in the spleen, we infected type I interferon receptor knockout (IFN-alpha/betaR(-/-)) mice via intranasal inoculation and observed the presence of viral genome-positive splenocytes at day 18 postinfection at approximately 10-fold-lower levels than in the genetically repaired marker rescue-infected mice. However, no mLANA-null virus reactivation from infected IFN-alpha/betaR(-/-) splenocytes was observed. To more thoroughly define a role of mLANA in MHV68 infection, we evaluated the capacity of an mLANA-null virus to establish and maintain infection apart from restriction in the lungs of immunocompetent mice. At day 18 following intraperitoneal infection of C57BL/6 mice, the mLANA-null virus was able to establish a chronic infection in the spleen albeit at a 5-fold-reduced level. However, as in IFN-alpha/betaR(-/-) mice, little or no virus reactivation could be detected from mLANA-null virus-infected splenocytes upon explant. An examination of peritoneal exudate cells (PECs) following intraperitoneal inoculation revealed nearly equivalent frequencies of PECs harboring the mLANA-null virus relative to the marker rescue virus. Furthermore, although significantly compromised, mLANA-null virus reactivation from PECs was detected upon explant. Notably, at later times postinfection, the frequency of mLANA-null genome-positive splenocytes was indistinguishable from that of marker rescue virus-infected animals. Analyses of viral genome-positive splenocytes revealed the absence of viral episomes in mLANA-null infected mice, suggesting that the viral genome is integrated or maintained in a linear state. Thus, these data provide the first evidence that a LANA homolog is directly involved in the formation and/or maintenance of an extrachromosomal viral episome in vivo, which is likely required for the reactivation of MHV68.
Paden
Clinton R
CR
Emory Vaccine Center, Emory University School of Medicine, 1452 Clifton Road, Suite 429, Atlanta, GA 30322, USA.
Forrest
J Craig
JC
Moorman
Nathaniel J
NJ
Speck
Samuel H
SH
D000281:Administration, Intranasal; D000818:Animals; D000956:Antigens, Viral / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D015967:Gene Expression Regulation, Viral; D016679:Genome, Viral; D007113:Immunity, Innate; D008168:Lung / Q000821:virology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout / Q000821:virology; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D010957:Plasmids; D017471:Receptors, Interferon / Q000235:genetics / Q000378:metabolism; D018144:Rhadinovirus / Q000235:genetics / Q000502:physiology*; D013154:Spleen / Q000166:cytology / Q000821:virology*; D014775:Virus Activation; D017735:Virus Latency
D000956:Antigens, Viral; D009687:Nuclear Proteins; D017471:Receptors, Interferon; C109540:latency-associated nuclear antigen
Curr Opin Microbiol. 1999 Aug;2(4):403-9
10458986
J Virol. 2003 Jul;77(13):7308-18
12805429
J Gen Virol. 1999 Oct;80 ( Pt 10):2729-2736
10573167
J Gen Virol. 1999 Jan;80 ( Pt 1):75-82
9934687
J Virol. 1991 Mar;65(3):1245-54
1847452
N Engl J Med. 1996 Jul 25;335(4):233-41
8657239
Science. 1999 Apr 23;284(5414):641-4
10213686
J Gen Virol. 2005 Mar;86(Pt 3):561-574
15722515
J Virol. 2002 Feb;76(4):1790-801
11799175
J Virol. 2007 Aug;81(15):8225-35
17522213
Virol J. 2006 Jun 06;3:43
16756670
Virology. 2007 Aug 1;364(2):317-29
17434559
J Virol. 2001 Apr;75(7):3250-8
11238851
J Virol. 2005 Aug;79(15):9480-91
16014911
Annu Rev Microbiol. 1987;41:543-71
2825588
Immunity. 1998 Sep;9(3):405-11
9768760
J Virol. 2007 Nov;81(21):11957-71
17699571
Adv Cancer Res. 1992;58:1-26
1312289
J Virol. 2005 Feb;79(4):2261-73
15681428
J Virol. 2001 Jan;75(1):458-68
11119614
Curr Top Microbiol Immunol. 1992;182:367-73
1337031
J Virol. 2003 Oct;77(19):10295-303
12970414
J Virol. 2009 Feb;83(3):1474-82
19019960
Proc Natl Acad Sci U S A. 1983 Apr;80(7):1987-91
6300885
Cancer. 1992 Jul 1;70(1):185-91
1318776
J Gen Virol. 2003 Dec;84(Pt 12):3405-3416
14645921
J Virol. 1998 Oct;72(10):8309-15
9733875
J Gen Virol. 2002 Sep;83(Pt 9):2269-2278
12185282
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5563-8
20212114
J Virol. 2003 Dec;77(23):12494-506
14610173
J Virol. 2010 Jan;84(2):674-85
19889763
Curr Top Microbiol Immunol. 2007;312:101-36
17089795
J Gen Virol. 1996 Nov;77 ( Pt 11):2819-25
8922476
J Virol. 2006 Feb;80(4):2055-62
16439562
Blood. 1999 Sep 1;94(5):1545-9
10477678
Am J Pathol. 2000 Mar;156(3):743-9
10702388
PLoS Pathog. 2009 Nov;5(11):e1000677
19956661
Blood. 2005 Mar 15;105(6):2510-8
15572586
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10989-94
12947043
Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):545-67
11313011
J Virol. 1999 Jun;73(6):4651-61
10233924
J Virol. 2008 Aug;82(15):7688-99
18495760
J Virol. 2009 Jul;83(13):6484-93
19386718
J Virol. 2003 Feb;77(4):2779-83
12552022
J Virol. 2003 Oct;77(19):10488-503
12970434
Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12250-5
11035774
EMBO J. 1993 Aug;12(8):3277-86
8393785
J Virol. 1993 Jan;67(1):82-92
8380099
J Gen Virol. 2004 Mar;85(Pt 3):609-613
14993644
J Virol. 1999 Mar;73(3):2232-42
9971806
Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):569-79
11313012
J Virol. 1996 Oct;70(10):6775-80
8794315
Lancet. 1990 May 5;335(8697):1047-50
1970369
Virology. 1999 Nov 25;264(2):254-64
10562490
J Clin Invest. 2004 Jan;113(1):124-36
14702116
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6978-82
1495989
J Virol. 2005 Nov;79(22):14149-60
16254350
J Virol. 1997 Aug;71(8):5915-21
9223481
J Virol. 2003 Aug;77(15):8310-21
12857900
J Virol. 2001 Sep;75(17):7882-92
11483733
J Virol. 1993 Mar;67(3):1292-9
8382295
Blood. 1995 Oct 1;86(7):2708-14
7670109
Blood. 1994 Nov 15;84(10):3307-10
7949085
Cell Host Microbe. 2007 Aug 16;2(2):106-18
18005725
Nat Med. 1997 Dec;3(12):1346-53
9396604
J Virol. 1999 Mar;73(3):2321-32
9971815
Proc Natl Acad Sci U S A. 1984 Jun;81(12):3806-10
6328526
Blood. 1995 Aug 1;86(3):1131-8
7620166
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6550-4
1713681
J Virol. 2001 Feb;75(4):1798-807
11160678
Science. 1997 Jun 20;276(5320):1851-4
9188529
J Exp Med. 2002 Nov 18;196(10):1363-72
12438427
J Virol. 2002 Nov;76(22):11677-87
12388727
J Mol Biol. 1976 Apr 15;102(3):511-30
178878
Nat Med. 2002 Oct;8(10):1086-7
12357244
J Virol. 2006 Mar;80(5):2243-56
16474132
Nature. 1985 Feb 28-Mar 6;313(6005):812-5
2983224
J Virol. 2008 Aug;82(15):7411-21
18480430
Trends Microbiol. 1998 Jul;6(7):276-82
9717216
PLoS Biol. 2004 Jun;2(6):e152
15208711
Science. 2006 Feb 10;311(5762):856-61
16469929
J Virol. 2001 Jun;75(11):4955-63
11333874
J Virol. 2003 Jul;77(13):7696-701
12805472